ArticleHepatology communications2021

Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA.

Atsushi Hosui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.